Posted by Michael Wonder on 07 Oct 2022
COVID-19 vaccine safety report (6 October 2022)
6 October 2022 - To 2 October 2022, the TGA has received 703 reports which have been assessed as likely to be myocarditis from about 44 million doses of Comirnaty (Pfizer) and 113 reports which have been assessed as likely to be myocarditis from about 5.4 million doses of Spikevax (Moderna).
To 2 October 2022, the TGA has received about 4,280 reports from approximately 3.7 million doses of Comirnaty (Pfizer) and Spikevax (Moderna) in 12-17 year olds. The most commonly reported reactions are chest pain, headache, dizziness, nausea and fever.
